151 件中 1 - 20 件目
英語 :Kodai Kawamura, et al , A randomized phase II study of 5-aminolevulinic acid hydrochloride and sodium ferrous citrate for the prevention of nephrotoxicity induced by cisplatin-based chemotherapy of lung cancer , Oncology , 2022
A randomized phase II study of 5-aminolevulinic acid hydrochloride and sodium ferrous citrate for the prevention of nephrotoxicity induced by cisplatin-based chemotherapy of lung cancer , 2022
英語 :3. Yoshida N., Okumura S., Sasaki T., Chiba S.-i., Sado M., Oyama K., Yoshida R., Hirai N., Minami Y., and Kitada M , SETD2 and miR-21 as therapeutic targets for NUT midline carcinoma , Journal of Cancer Science and Clinical Therapeutics , 2022
英語 :2. Yamamoto G, Asahina H, Honjo O, Sumi T, Nakamura A, Ito K, Kikuchi H, Hommura F, Honda R, Yokoo K, Fujita Y, Oizumi S, Morita R, Ikezawa Y, Tanaka H, Kimura N, Sasaki T, Sukoh N, Takashina T, Harada T, Dosaka-Akita H, and Isobe H, , First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002) , Sci Rep . , 2021
英語 :1. Hirai N, Hatanaka Y, Hatanaka KC, Uno Y, Chiba SI, Umekage Y, Minami Y, Okumura S, Ohsaki Y, Sasaki T. , Cyclin-dependent kinase 4 upregulation mediates acquired resistance of dabrafenib plus trametinib in BRAF V600E-mutated lung cancer , Transl Lung Cancer Res . , 2021
Cyclin-dependent kinase 4 upregulation mediates acquired resistance of dabrafenib plus trametinib in BRAF V600E-mutated lung cancer , 2021
英語 :Kosaka A., Yajima Y., Hatayama M., Ikuta K., Sasaki T., Hirai N., Yasuda S., Nagata M., Hayashi R., Harabuchi S., Ohara K., Ohara M., Kumai T., Ishibashi K., Hirata-Nozaki Y., Nagato T., Oikawa K., Harabuchi Y., Celis E., Okumura T., Ohsaki Y., Kobayashi H., and Ohkuri T. , A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy , Cancer Science , 2021
英語 :5. Okazaki S, Sasaki T, Yasuda S, Abe M, Yoshida N, Yoshida R, Ishibashi K, Minami Y, Okumura S, Chiba S, Takei H, Hayashi R, Nagato T, Kobayashi H, Sugitani A, Ono Y, Mizukami Y, Kitada M, Ohsaki Y, , The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancer , Oncology Letters , 2021
英語 :Ariyasu R, Uchibori K, Sasaki T, Tsukahara M, Kiyotani K, Yoshida R, Ono Y, Kitazono S, Ninomiya H, Ishikawa Y, Mizukami Y, Yanagitani N, Fujita N, Nishio M, Katayama R , Monitoring EGFR C797S mutation in Japanese NSCLC patients with serial cell free DNA evaluation using digital droplet PCR , Cancer Science , 2021
英語 :Ninomiya K, Sasaki T, Hotta K.,et al , Japanese Lung Cancer Society Guideline for stage IV non‑small cell lung cancer with epidermal growth factor receptor mutations , JTO Clinical and Research Reports , 2021
英語 :Yasuhiro Umekage, Shunsuke Okumura, Toshiyuki Tenma, Yoshihiro Kazebayashi, Noriko Hirai, Yoshinori Minami, Kazushi Doshita, Takaaki Sasaki, Yasushi Yamamoto, Yoshinobu Ohsaki , Acute eosinophilic pneumonia following inhalation of turpentine oil: A case report , Respir Med Case Rep , 2020
英語 :Fukudo M, Sasaki T, Ohsaki Y , PD-1 Blockers: Staying Long in the Body and Delayed Toxicity Risks. , Journal of thoracic oncology , 2020
英語 :Hirai N., Sasaki T., Okumura S., et al. , Novel ALK-specific mRNA in situ hybridization assay for non-small-cell lung carcinoma , Translational Lung Cancer Research , 2020
英語 :Hirai N., Sasaki T., Okumura S., Minami Y., Chiba S., Ohsaki T , Monomerization of ALK Fusion Proteins as a Therapeutic Strategy in ALK-Rearranged Non-Small Cell Lung Cancers , Frontiers in Oncology , 2020
英語 :Tsukita Y., Miyauchi E., Sasaki T., Fukudo M.,et al , Immunotherapy-related hepatitis and thrombocytopenia induced by the very low dose of only 90 mg of atezolizumab , European Journal of Cancer , 2020
英語 :Usuda J, Inoue T, Tsuchid T, Ohtani K, Maehara S, Ikeda N, Ohsaki Y, Sasaki T, Oka K, , Clinical trial of photodynamic therapy for peripheral-type lung cancers using a new laser device in a pilot study. , Photodiagnosis and photodynamic therapy , 2020
英語 :Sakakibara J., Kitai H., Sasaki T., Yoshida R., et al , Response to Crizotinib Re-administration After Progression on Lorlatinib in a Patient With ALK-rearranged Non-small-cell Lung Cancer. , Clinical lung cancer , 2019
英語 :Yoshida R, Sasaki T, Umekage Y, Tannno S, , Highly Sensitive Detection of ALK Resistance Mutations in Plasma Using Droplet Digital PCR , BMC Cancer , 2018
Highly Sensitive Detection of ALK Resistance Mutations in Plasma Using Droplet Digital PCR , 2018
英語 :Harada, T. and Amano, T. and Ikari, T. and Takamura, K. and Ogi, T. and Fujikane, T. and Fujita, Y. and Taima, K. and Tanaka, H. and Sasaki, T. and Okumura, S. and Sugawara, S. and Yokouchi, H. and Yamada, N. and Morikawa, N. and Dosaka-Akita, H. and Isobe, H. and Nishimura, M. , Rikkunshito for preventing chemotherapy-induced nausea and vomiting in lung cancer patients: Results from 2 prospective, randomized phase 2 trials , Frontiers in Pharmacology, 8 (JAN) (972 - ) , 2018
英語 :Narumi, Y. and Yoshida, R. and Minami, Y. and Yamamoto, Y. and Takeguchi, S. and Kano, K. and Takahashi, K. and Saito, T. and Sawada, J. and Terui, H. and Katayama, T. and Sasaki, T. and Ohsaki, Y. , Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: The first report , BMC Cancer, 18 (1) (95 - ) , 2018
英語 :Ohsaki, Y. and Sasaki, T. and Endo, S. and Kitada, M. and Okumura, S. and Hirai, N. and Kazebayashi, Y. and Toyoshima, E. and Yamamoto, Y. and Takeyama, K. and Nakajima, S. and Sakata, I. , Observation of Zn-photoprotoporphyrin red Autofluorescence in human bronchial cancer using color-fluorescence endoscopy , BMC Cancer, 17 (1) (289 - ) , 2017
英語 :Yoshida, R. and Sasaki, T. and Ohsaki, Y. , EGFR and KRAS Mutations in Triple-Mutated Lung Cancer , Journal of Thoracic Oncology, 12 (7) (e92 - e93) , 2017
Copyright (C) 2012~ Asahikawa Medical University, All Rights Reserved.